1st Quarter - Report · 2026

Filing UUID: fc3fdc6d-c12b-4edb-97fb-49bc73e33a09
Type: Q1 — 1st Quarter - Report
Period: first_quarter
Year: 2026
Posted: 2026-04-17 18:42:28
Income (reported): $60,000
Expenses (reported): —
Filing document: Open on lda.senate.gov

Registrant (lobbying firm)

ARNOLD & PORTER KAYE SCHOLER LLP

Law firm

Contact: NICHOLAS TOWNSEND
Phone: +1 202-942-5249
Address: zip:20001, city:Washington, state:DC, street:601 Massachusetts Ave. NW

Client

GENETIX BIOTHERAPEUTICS, INC.

Biotechnology and pharmaceutical company.

State: MA
Country: US
Effective date: 2023-05-01

Issues lobbied + lobbyists

`MMM` — Medicare/Medicaid

Issues and legislation related to access to gene therapies and treatment of rare diseases.

Lobbyists: EUGENIA PIERSON; BOBBY MCMILLIN; SONJA NESBIT; LUKE ALBERT; RON KIND

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

`HCR` — Health Issues

Issues and legislation related to access to gene therapies and treatment of rare diseases.

Lobbyists: EUGENIA PIERSON; BOBBY MCMILLIN; SONJA NESBIT; LUKE ALBERT; RON KIND

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

`PHA` — Pharmacy

Issues related to regulatory incentives for rare disease therapies.

Lobbyists: BOBBY MCMILLIN

Government entities lobbied: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.